| Gene symbol | GPC3 | Synonyms | DGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB, SGBS, SGBS1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq26.2 | dbXrefs | |
| Description | glypican 3 | ||||
| GTO ID | GTC1113 |
| Trial ID | JPRN-jRCT1080225004 |
| Disease | Solid Tumor |
| Altered gene | GPC3 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | TAK-102 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | CAR-T Long Term Follow Up Study |
| Year | 2020 |
| Country | Japan |
| Company sponsor | Novartis Pharma. K.K. |
| Other ID(s) | NCT02445222|JapicCTI-205095 |
| Cohort1: dose level 1 | |||||||
|
|||||||
| Cohort2: dose level 2 | |||||||
|
|||||||
| Cohort3: dose level 3 | |||||||
|
|||||||